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Abstract 
 
This study aimed to review the risk factors and clinical outcomes of patients undergoing pars planar vitrectomy 
(PPV) for breakthrough bleeding (BTB) from age related macular degeneration (AMD) and polypoidal choroidal 
vasculopathy (PCV). We performed a retrospective review of medical records of 346 patients operated by the 
vitreoretinal unit at Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Kuala Lumpur, Malaysia from 
January 2008 - June 2011. We found eight eyes of 8 patients with AMD/IPCV-related BTB who underwent PPV. 
Mean age of patients was 64.4 years (range 41-80 years) with 5 males. Five were Chinese. Duration of symptoms 
ranged from days to months. Four patients were on anti-coagulants. Two had history of prior photodynamic therapy. 
There were five cases of PCV, of which three were macular in location. All three cases of AMD were macular. 
Intraoperative intravitreal ranibizumab injection was given in three cases and two had combined vitrectomy and 
cataract extraction. All cases reported improvement in visual acuity with four cases achieving 6/60 or better post 
operatively including two cases of extramacular PCV achieving 6/9 vision. Mean follow-up was 60 weeks. 
Postoperative complications included retinal tear and detachment in one case, reattached on reoperation. Six patients 
had a history of hypertension including one individual with stroke. Our small series indicates a predominance of 
Chinese individuals with BTB. Usage of anticoagulants and hypertension may be a predisposing factor. Better visual 
prognosis occurs with extramacular lesions which tend to be of PCV type. 
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Introduction 
 
Age related macular degeneration (AMD) is one of the 
most common causes of reduced visual acuity in the 
aged population. Exudative AMD is characterized by 
the presence of subretinal neovascularisation with 
subretinal haemorrhages, exudation and pigment 
epithelial detachments. Recently, a disease that has 
clinical features similar to AMD has been found to 
have a higher prevalence in Asian populations, namely 
polypoidal choroidal vasculopathy (PCV) (1). Unlike 
cataract and glaucoma in which there are effective 
treatments which can completely cure or control the 
disease, AMD and PCV remain diseases that carry 
heavy financial burdens for those afflicted and may 
result in persistent, poor central vision despite 
treatment. 
 
Subretinal haemorrhage following choroidal 
neovascular membrane secondary to age-related 
macular degeneration or idiopathic polypoidal 
choroidal vasculopathy (PCV) is an important sight-
threatening condition (1). A massive intraocular 
haemorrhage in the course of age-related macular 
degeneration (AMD) is a devastating event which 
often requires immediate surgical intervention. It can 
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also be a diagnostic and treatment dilemma. There is 
evidence that anticoagulant therapy prescribed for 
vascular or cardiac indications plays a role in the 
development of a massive haemorrhage (2-4). 
 
The aim of this retrospective review was to review the 
ocular and systemic risk factors and clinical outcomes 
of patients undergoing pars planar vitrectomy (PPV) 
for breakthrough bleeding (BTB) from age related 
macular degeneration (AMD) and polypoidal 
choroidal vasculopathy (PCV). 
 
Materials and methods 
 
A retrospective review of 346 patients operated by the 
vitreoretinal unit in Universiti Kebangsaan Malaysia 
Medical Centre (UKMMC) in Kuala Lumpur from 
January 2008 - June 2011 was conducted to detect all 
cases of vitreous haemorrhage secondary to 
breakthrough bleeding (BTB) from AMD or PCV 
which underwent pars planar vitrectomy for clearance 
of the haemorrhage. The study was conducted in 
accordance with the Declaration of Helsinki. All 
patients had signed an informed consent form prior to 
vitrectomy surgery. Pars planar vitrectomy was 
performed by one surgeon and was either 20G or 23G 
pars planar vitrectomy using the MilleniumTM (Bausch 
and Lomb, London, UK) or AccurusTM (Alcon 
laboratories, Texas, USA) vitrectomy machines. 
Patients underwent subsequent fundus fluorescein and 
indocyanine green angiography with Heidelberg 
Retinal AngiogramTM (Heidelberg Engineering, USA) 
if angiography had not been performed prior to the 
bleed or for better localization of the membrane or 
polyp or if the lesions looked active and were not 
fibrotic.  The patient medical records were reviewed to 
collect information on the demographics, the fundus 
photography and the angiography confirming 
diagnosis of AMD and PCV. The data was analysed 
by SPSS version 16. 
 
Results  
 
Eight eyes of 8 patients with AMD/PCV-related BTB 
who underwent PPV were included. Table 1 shows the 
demographics and clinical data of the patients. The 
mean age of patients was 64.4 years (range 41-80 
years). Males just outnumbered females. The majority 
of patients were Chinese (n=5).  
 
Photodynamic therapy (PDT) was performed 
previously in two eyes including one eye with 
previous PDT and anti-VEGF. Five cases out of the 
eight had components of idiopathic polypoidal 
choroidal vasculopathy (PCV) and three of them were 
macular in location. (Patient 6, Figure 1) Three cases 
with features of AMD were all macular in location and 
had fibrotic elements. (Table 1)  (Patient 5, Figure 2 
and Patient 7, Figure 3) Only one case of PCV with 
BTB was in fibrotic stage. (Patient 2, Figure 4) Four 
cases of PCV were in the active stage. Small gauge 
(23G) vitrectomy was used in all cases except one. 
Two cases were combined with phacoemulsification. 
Vision at presentation was poor in all cases (counting 
finger or worse).  The vision in all patients improved 
after vitrectomy. However, only half achieved 6/60 or 
better vision. Two patients achieved vision better than 
6/12 who were the two patients with extramacular 
PCV. (Patient 3, Figure 5) Mean follow up was 60 
weeks (range 4-28 months).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Fundus photograph of the right eye of Patient 6 
showing Exudative AMD involving the right fundus as 
evidenced by subretinal hard exudation and haemorrhagic 
pigment epithelial detachment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Left fundus photograph of Patient 5 showing 
extensive subretinal fibrosis in a submacular location with 
altered blood. Other interesting features in the photograph 
include the presence of atherosclerosis in the inferotemporal 
arteriole (small white arrow). There is also AV nipping and 
arteriolar narrowing consistent with Grade 2 hypertensive 
retinopathy and a flame shaped haemorrhage (small dark 
arrow)
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Table 1: Shows the demographics and clinical features of the patients
 
 
 
Patient 
No 
Age (yrs at 
diagnosis)/ 
Gender/ 
Ethnicity 
 
Vision at 
presentation 
(affected 
eye) 
 
Duration 
of 
symptoms 
Duration 
of 
follow-
up 
(weeks) 
Treatments 
prior to BTB 
Vitreoretinal 
procedure 
Causative 
Lesion 
Location Stage Systemic 
disease 
Post-
operative 
vision 
Anticoagulant 
usage 
Complications 
1 75/F/C PL 5 months 214 Nil PPV/ PEA/ IOL AMD  submacular fibrosis DM with 
mild 
DR/IHD/HPT 
CF warfarin 
 
 
2 52/F/C HM 2 days 132 Nil PPV/SF6 PCV submacular fibrosis NIL CF NIL Retinal tear, 
cataract 
3 41/F/O HM 1week 19 Nil PPV/ SF6 PCV juxta- foveal active NIL 6/9 NIL Retinal tear 
4 58/M/M HM 1 month 47 PDT PPV/ ranibizumab PCV Temporal 
extramacular 
Pulsating 
(active) 
DM with  
mild 
DR/HPT 
6/9 NIL Cataract 
5 80/M/C HM 2 weeks 19 Nil PPV AMD submacular fibrosis DM with 
mild DR/IHD 
CF ticlopidine  
6 74/M/C PL 1 week 15 PDT/ 
ranibizumab 
PPV PCV submacular Polyps 
(active) 
Stroke 6/36 aspirin  
7 70/M/I HM 2 week 16 Nil PPV/ ranibizumab AMD submacular fibrosis IHD CF clopidogrel  
8 65/M/C HM 1month 16 Nil PPV/ PEA/ IOL/ 
ranibizumab 
PCV submacular active NIL 6/60 NIL  
Key: Gender: M-
male; F-
female/ 
Ethnicity: 
M-Malay; 
C-Chinese; 
I-Indian; O- 
Others 
(Indonesian) 
HM – hand 
motion; PL – 
perception to 
light 
 
  PDT- 
photodynamic 
therapy 
PPV-23G pars 
planar vitrectomy; 
*PPV–20G PPV; 
PEA- 
phacoemulsification; 
IOL–intraocular lens 
implantation; SF6– 
sulphur hexafluoride 
gas 
PCV– 
polypoidal 
choroidal 
vasculopathy; 
AMD – age 
related 
macular 
degeneration 
  DM– 
diabetes 
mellitus; DR 
–diabetic 
retinopathy; 
IHD– 
ischaemic 
heart disease 
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Figure 3: Right fundus composite photograph showing 
extensive submacular scarring in patient 7 in association 
with subretinal exudation and haemorrhage inferior to the 
arcades indicating still active disease components. 
 
Figure 4: Right fundus photograph of Patient 2’s operated 
eye with subretinal altered blood and scarring following 
vitrectomy and silicone oil for PCV at the macula. 
 
Four patients were observed following the BTB and 
did not receive any treatment until their last review 
with stable visions. Patient 6 underwent indocyanine 
green angiography 1 week following vitrectomy which 
revealed an extensive cluster of polyps, branching 
vascular network and feeder vessel (Patient 7, Figure 
6). He received PDT and intravitreal ranibizumab 0.5 
mg/ 0.05 ml injection and was stable until final review. 
Patient 4 with extramacular PCV on ICGA (Patient 6, 
Figure 7) was treated with laser photocoagulation. One 
patient defaulted 1 month after vitrectomy. One patient 
underwent angiography (Patient 8) but declined further 
treatment. 
 
Discussion 
 
Spontaneous vitreous haemorrhage in elderly patients 
with no prior history of eye disease is a diagnostic and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Fundus photograph of Patient 3’s left eye showing 
the fresh and dense premacular (subhyaloid haemorrhage) 
with darker subretinal bleed involving the superior fundus 
just above the disc. The subretinal blood arose from a cluster 
of polyps (PCV) just near the disc sparing the fovea. Hence 
post-operative vision was good at 6/9. 
 
treatment dilemma. The differential diagnoses include 
ischaemic retinal conditions with neovascularisation 
such as vein occlusion or diabetic retinopathy, retinal 
tear or rhegmatogenous retinal detachment, posterior 
vitreous detachment and AMD or PCV.  Interestingly, 
BTB necessitating vitrectomy was performed in a 
mere 2.3% of vitrectomy surgeries at our centre 
suggesting an overall low rate of breakthrough 
bleeding in all forms of AMD or PCV which 
eventually require vitrectomy.  
 
The large number of PCV lesions found in this study 
(half) is reflective of the Asian parentage of the 
subjects (5). PCV accounts for about ¼ to ½ of cases 
manifesting as exudative AMD in Asia (5,6) compared 
to approximately 10% of the Caucasian population (6).  
 
BTB is often related to PCV lesions which are prone 
to sudden torrential bleeds. The average age of onset 
of PCV is 65 years (7). The mean age of this small 
local series was 64.4 years with a slight male 
preponderance similar to the findings of Uyama M et 
al7 and A K H Kwok et al (8). In this case series of 
patients with BTB, there was a large number of 
Chinese highlighting a higher predisposition to BTB 
secondary to AMD or PCV in Chinese individuals 
(5,6). Furthermore, this group is disproportionate to 
the ethnic distribution of the surrounding population 
which has a Malay majority.  
 
Seventy percent of the lesions in this case series are 
located in the macula. In the cases due to AMD 
neovascular membranes, the lesions were invariably at 
the macula as in other series (8). In contrast, PCV lesions  
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Figure 6: The right fundus indocyanine green angiogram of 
Patient 7 shows no active lesions and mainly subretinal 
exudative scarring.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Indocyanine green angiogram of Patient 6’s right 
eye showing a cluster of large polyps (small arrows, not all 
are marked) and large, wide caliber of branching vascular 
network (medium arrow) associated with a large feeder 
vessel (large arrow). Without vitrectomy, such good view for 
angiography and ultimately targeted therapy would have 
been impossible. 
 
can be peripapillary, at the macula or in the periphery 
with a majority at the periphery. Interestingly, a 
proportion of PCV lesions were located outside the 
macula and these lesions had the best visual prognosis 
in our series because the macula was spared.  
 
Other interesting features of the study group included 
the heterogenous but common usage of anticoagulant 
(up to half). Usage of anticoagulants or 
antithrombotics clearly predispose them to serious 
haemorrhagic complications including BTB. Studies 
strongly support this observation (2,3,4). 
Anticoagulant medication probably poses a more 
significant risk in the development of a massive 
intraocular haemorrhage in patients with exudative 
AMD, compared to those on antiplatelet medication 
(2) but we had at least one patient on aspirin and one 
on ticlopidine at the time of BTB. Kiernan DF et al 
found an annual incidence of vitreous haemorrhage in 
Exudative AMD of 0.1% in those who are taking 
anticoagulants and antiplatelets agents, and 2.5 times 
less in those who are not on anti coagulants (0.04%) 
(4). 
 
In our case series, two patients had had previous PDT. 
PDT for eyes with a large PCV lesions may be another 
risk for serious haemorrhagic ocular complications (9). 
In fact, up to 30% of PCV lesions which had received 
PDT subsequently bled subretinally and of these, up to 
20% had vitreous haemorrhages (9). The risk of BTB 
seemed to be related to the size of area of branching 
vascular network with larger networks at higher risk of 
BTB.   
 
El Baba et al. found a positive history of systemic 
hypertension and cardiovascular diseases in 40% of 
patients with AMD (3). The occurrence of 
hypertension is no surprise in an aged population with 
AMD. However, the high proportion of hypertension 
in three quarters of our group of patients requiring 
vitrectomy for BTB suggests an association of 
hypertension with BTB.  
 
Vitrectomy is beneficial for improving vision in cases 
of breakthrough vitreous haemorrhage. The functional 
outcome in our patients with BTB from AMD and 
PCV is acceptable where half of them achieved 6/60 or 
better. All eyes post operatively had anatomical 
success and good functional success in macula sparing 
lesions. Edward Roufail et al 2008, found that surgical 
and functional outcome in combined cataract and BTB 
was poor in AMD most likely due to the advanced 
stage and location of lesions (10). Submacular fibrosis 
was observed in patients with low post-operative 
visual acuity and limited visual gain. It is possible that 
bleeding from submacular networks or polyps 
promoted fibrosis and healing of the inciting lesions 
leading to fibrotic stage AMD and PCV. 
 
The visual outcome in PCV seems better compared to 
AMD because of bleeding from extramacular sites. 
The same findings were noted by Jung Jae Ho et al in 
their retrospective review, which found that functional 
outcomes of vitrectomy for vitreous haemorrhage 
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associated with AMD were inferior to outcomes of the 
PCV group (11).  
 
This study sets the scene for further investigation 
involving a large cohort of AMD/ PCV patients 
followed over time to detect risk factors for bleeding. 
Nonetheless, treatment for BTB requires vitrectomy to 
improve view for further investigation and treatment 
of the underlying polyp, branching vascular network 
or choroidal neovascularisation which should not be 
different from the usual approach. 
 
Conclusion 
 
Vitrectomy for BTB in AMD/PCV is successful in 
improving functional outcomes in only half of those 
undergoing surgery despite the excellent anatomical 
outcomes. Hence our observations suggest that 
systemic hypertension in AMD and PCV patients, 
particularly in those with a single remaining good eye, 
be well controlled to reduce the risk of BTB. We also 
suggest judicious usage of anticoagulants of any kind 
in these patients to prevent BTB. This requires 
communication between physician and 
ophthalmologist for the well-being and quality of life 
of elderly patients. Chinese patients have a genetic 
predisposition to BTB. Counselling of patients with 
AMD or PCV should include the risk of BTB. 
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